Overview
Nordic care firm's Q4 revenue missed analyst expectations, with negative organic growth
Company acquired Familiehjelpgruppen in Norway, enhancing preventive care services
Board proposed a 35% dividend increase for 2025 financial year
Outlook
Humana plans growth projects worth approximately SEK 450 mln for 2026
Company aims to achieve net zero emissions by 2050
Humana plans new nursing home and LSS group home in Sollentuna by 2028
Result Drivers
ACQUISITION IMPACT - Acquisition of Familiehjelpgruppen in Norway strengthens preventive care offerings
CLIMATE TARGETS - Climate targets validated by SBTi, aiming for net zero emissions by 2050
PROJECT PIPELINE - Signed growth projects of approximately SEK 450 million to drive future growth
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue | Miss | SEK 2.48 bln | SEK 2.56 bln (3 Analysts) |
Q4 Net Income | SEK 26 mln | ||
Q4 Adjusted Operating Profit | SEK 87 mln | ||
Q4 Operating Profit | SEK 83 mln | ||
Q4 Organic Growth | -1.90% |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Humana AB is SEK60.00, about 20.6% above its February 5 closing price of SEK49.75
The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 7 three months ago
Press Release: ID:nMFN176drH
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)